Susquehanna International Group, LLP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 96,909 shares of RVPH stock, worth $43,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,909
Previous 231,450
58.13%
Holding current value
$43,609
Previous $219,000
83.56%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RVPH
# of Institutions
55Shares Held
14.5MCall Options Held
4.9MPut Options Held
29.7K-
Diadema Partners LP Morristown, NJ2.74MShares$1.23 Million0.32% of portfolio
-
Armistice Capital, LLC New York, NY2.69MShares$1.21 Million0.02% of portfolio
-
Heights Capital Management, Inc San Francisco, CA1.83MShares$823,4560.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$811,8410.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.49MShares$669,6190.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $9.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...